[11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy

Area of Science:

• Neuroscience
• Radiology
• Neuropathology

Background:

• Microglia, the brain's resident immune cells, become activated in response to neuronal injury.
• Activated microglia express specific binding sites for the radioligand (R)-PK11195.
• Multiple System Atrophy (MSA) is a neurodegenerative disease characterized by neuronal loss and microglial activation.

Purpose of the Study:

• To investigate the utility of [11C](R)-PK11195 Positron Emission Tomography (PET) for in vivo imaging of microglial activation in patients with MSA.
• To correlate the distribution of microglial activation with known neuropathological changes in MSA.

Main Methods:

• Utilized [11C](R)-PK11195, a radioligand that binds to activated microglia.
• Employed Positron Emission Tomography (PET) imaging to localize and quantify [11C](R)-PK11195 binding in vivo.
• Compared PET findings with established neuropathological distribution patterns in MSA.

Main Results:

• [11C](R)-PK11195 PET demonstrated increased binding in key brain regions affected by MSA.
• Elevated radioligand uptake was observed in the dorsolateral prefrontal cortex, putamen, pallidum, pons, and substantia nigra.
• The observed pattern of microglial activation mirrored the known neuropathological hallmarks of MSA.

Conclusions:

• [11C](R)-PK11195 PET is a valuable tool for visualizing and quantifying in vivo microglial activation in MSA.
• This imaging modality can serve as a biomarker for disease activity and progression in MSA.
• PET imaging with [11C](R)-PK11195 aids in characterizing the in vivo neuropathology of MSA.